These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12643993)

  • 21. Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria.
    Baird JK
    Travel Med Infect Dis; 2013; 11(1):60-5. PubMed ID: 23454204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Host Genetic Polymorphisms on the Efficacy of the Radical Cure Malaria Drug Primaquine.
    Nain M; Mohan M; Sharma A
    Am J Trop Med Hyg; 2022 Jan; 106(3):764-767. PubMed ID: 35008050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically.
    Taylor AR; Watson JA; Chu CS; Puaprasert K; Duanguppama J; Day NPJ; Nosten F; Neafsey DE; Buckee CO; Imwong M; White NJ
    Nat Commun; 2019 Dec; 10(1):5595. PubMed ID: 31811128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax.
    Spudick JM; Garcia LS; Graham DM; Haake DA
    J Clin Microbiol; 2005 Feb; 43(2):978-81. PubMed ID: 15695723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy.
    Goller JL; Jolley D; Ringwald P; Biggs BA
    Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of Plasmodium vivax malaria.
    Baird KJ; Maguire JD; Price RN
    Adv Parasitol; 2012; 80():203-70. PubMed ID: 23199489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective Study of Plasmodium vivax Malaria Recurrence after Radical Treatment with a Chloroquine-Primaquine Standard Regimen in Turbo, Colombia.
    Zuluaga-Idárraga L; Blair S; Akinyi Okoth S; Udhayakumar V; Marcet PL; Escalante AA; Alexander N; Rojas C
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4610-9. PubMed ID: 27185794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasmodium vivax malaria recurrence according to the use of primaquine: analysis of longitudinal descriptive studies].
    Carmona-Fonseca J
    Rev Bras Epidemiol; 2012 Sep; 15(3):488-503. PubMed ID: 23090298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
    Carmona-Fonseca J; Alvarez G; Maestre A
    Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic failure of primaquine and need for new medicines in radical cure of Plasmodium vivax.
    Thomas D; Tazerouni H; Sundararaj KG; Cooper JC
    Acta Trop; 2016 Aug; 160():35-8. PubMed ID: 27109040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
    Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
    N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand.
    Wilairatana P; Silachamroon U; Krudsood S; Singhasivanon P; Treeprasertsuk S; Bussaratid V; Phumratanaprapin W; Srivilirit S; Looareesuwan S
    Am J Trop Med Hyg; 1999 Dec; 61(6):973-7. PubMed ID: 10674681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.
    Silvino ACR; Kano FS; Costa MA; Fontes CJF; Soares IS; de Brito CFA; Carvalho LH; Sousa TN
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122891
    [No Abstract]   [Full Text] [Related]  

  • 36. A Malaria Case Followed By Relapse.
    Sümer Ş; Aktuğ Demir N; Ural O; Çimen G; Yalçınkaya E
    Turkiye Parazitol Derg; 2018 Jun; 42(2):161-163. PubMed ID: 29780011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia.
    Smoak BL; DeFraites RF; Magill AJ; Kain KC; Wellde BT
    Am J Trop Med Hyg; 1997 Feb; 56(2):231-4. PubMed ID: 9080885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of primaquine glyco-conjugates as potential tissue schizontocidal antimalarial agents.
    Azad CS; Saxena M; Siddiqui AJ; Bhardwaj J; Puri SK; Dutta GP; Anand N; Saxena AK
    Chem Biol Drug Des; 2017 Aug; 90(2):254-261. PubMed ID: 28102941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
    Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.